Nuclear Medicine: Page 407

Draxis Health turns in record Q1

By AuntMinnie.com staff writers

Canadian radiopharmaceutical manufacturer Draxis Health reported record revenues of $10 million (U.S.) in the first quarter of 2002, up 18% from the $8.4 million booked in the first quarter last year.

May 15, 2002

FDG-PET results keep colorectal cancer patients out of the OR

By Shalmali Pal

With a relapse rate as high as 40%, colorectal cancer patients clearly need better preoperative assessment. Australian researchers investigated whether FDG-PET could be the modality to pick up where conventional imaging, and CT in particular, leaves off.

May 6, 2002

Molecular Imaging brings PET to St. Pete

By AuntMinnie.com staff writers

Mobile P.E.T. Systems subsidiary Molecular Imaging has joined forces with St. Pete MRI of Saint Petersburg, FL.

April 30, 2002

Digirad raises $16 million

By AuntMinnie.com staff writers

Digital gamma camera developer Digirad has secured commitments for $16 million in equity funding.

April 24, 2002

Syncor posts sales gains in Q1

By AuntMinnie.com staff writers

Radiopharmaceutical provider Syncor International reported first-quarter net sales of $215.5 million, up 18.8% compared from the $181.4 million reported in the same period last year.

April 23, 2002

GE debuts PET learning program

By AuntMinnie.com staff writers

GE Medical Systems has introduced an interactive distance PET learning program targeted at physicians and technologists.

April 22, 2002

CMS panel dashes hopes for PET Alzheimer’s payments

By AuntMinnie.com staff writers

A panel of the Centers for Medicare and Medicaid Services has affirmed a lower panel’s rejection of PET coverage for the diagnosis and management of Alzheimer’s disease.

April 21, 2002

Digirad slashes work force, CEO resigns

By AuntMinnie.com staff writers

Digital gamma camera developer Digirad of San Diego has slashed its workforce by one-third and its CEO has left the company, according to an article in the San Diego Union-Tribune. The company has indefinitely postponed its plans to go public, according to the newspaper.

April 10, 2002

Prostascint (111In-Capromab Pendetide) (CYT-356)

By Scott Williams

April 2, 2002

PET > PET tumor imaging > Colon Cancer

By Scott Williams

April 2, 2002

Antimyosin Antibodies: Myoscint

By Scott Williams

April 2, 2002

PET > PET tumor imaging > Breast Cancer

By Scott Williams

April 2, 2002

Previous Page

Page 407 of 440

Next Page